NY AG James Slams $720M Opioid Settlement on Drug Cos

New YORK – In a groundbreaking move against pharmaceutical giants, New York Attorney General Letitia James announced a historic $720 million settlement from eight drug companies. The funds are a direct response to their role in manufacturing opioids that have caused an epidemic of addiction across the nation.

Attorney General James has been relentless in her pursuit of justice for the communities ravaged by the crisis, securing over $3 billion to date. ‘For years, drug companies prioritized profits at the expense of New Yorkers trapped in deadly addictions,’ James said. ‘These resources will help us begin to heal and ensure that those most affected get the support they need.’

The eight companies involved are Mylan (now Viatris), Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus. Payments will commence in 2026, with Mylan, Hikma, Amneal, and Indivior also providing treatment medications worth $86 million. Companies have agreed to restrictions on marketing opioids and implementing monitoring systems for suspicious orders.

The settlement negotiations were led by Special Counsel Monica Hanna and Assistant Attorney General Matthew Conrad. The attorneys general of California, Colorado, Illinois, North Carolina, Oregon, Tennessee, Utah, and Virginia also played a role in the settlements.

James is a national leader in combating the opioid crisis, securing significant settlements from Purdue, Teva Pharmaceuticals, Johnson & Johnson, Mallinckrodt, Allergan, Endo, McKesson, Cardinal Health, Amerisource Bergen, CVS, Walgreens, Walmart, McKinsey & Company, and Publicis Health. This victory is a testament to her commitment to holding the pharmaceutical industry accountable for the human cost of their actions.

RELATED: NY AG Slams Rochester Property Firm for Tenant Rights Violations

RELATED: NY AG Slams Landsman over Rochester Tenant Abuse